Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Melatonin receptors: molecular pharmacology and signalling in the context of system bias
复制标题
DOI:
10.1111/bph.13950
复制
发表时间:
2018-08-01
影响因子:
7.3
通讯作者:
Jockers, Ralf
中科院分区:
文献类型:
--
作者:
Cecon, Erika;Oishi, Atsuro;Jockers, Ralf
Melatonin, N-acetyl-5-methoxytryptamine, an evolutionally old molecule, is produced by the pineal gland in vertebrates, and it binds with high affinity to melatonin receptors, which are members of the GPCR family. Among the multiple effects attributed to melatonin, we will focus here on those that are dependent on the activation of the two mammalian MT1 and MT2 melatonin receptors. We briefly summarize the latest developments on synthetic melatonin receptor ligands, including multi-target-directed ligands, and the characterization of signalling-biased ligands. We discuss signalling pathways activated by melatonin receptors that appear to be highly cell- and tissue-dependent, emphasizing the impact of system bias on the functional outcome. Different proteins have been demonstrated to interact with melatonin receptors, and thus, we postulate that part of this system bias has its molecular basis in differences of the expression of receptor-associated proteins including heterodimerization partners. Finally, bias at the level of the receptor, by the expression of genetic receptor variants, will be discussed to show how a modified receptor function can have an effect on the risk for common diseases like type 2 diabetes in humans.